The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin

被引:92
|
作者
Zeisig, DT
Bittner, CB
Zeisig, BB
García-Cuéllar, MP
Hess, JL
Slany, RK
机构
[1] Univ Erlangen Nurnberg, Dept Genet, D-91058 Erlangen, Germany
[2] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
关键词
ENL; MLL; leukemia; histone; chromatin;
D O I
10.1038/sj.onc.1208699
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mixed lineage leukemia (MLL) fusion proteins are derived from translocations at 11q23 that occur in aggressive subtypes of leukemia. As a consequence, MLL is joined to different unrelated proteins to form oncogenic transcription factors. Here we demonstrate a direct interaction between several nuclear MLL fusion partners and present evidence for a role of these proteins in histone binding. In two-hybrid studies, ENL interacted with AF4 and AF5q31 as well as with a fragment of AF10. A structure-function analysis revealed that the AF4/AF5q31/AF10 binding domain in ENL coincided with the C-terminus that is essential for transformation by MLL-ENL. The ENL/AF4 association was corroborated by GST-pulldown experiments and by mutual coprecipitation. Both proteins colocalized in vivo in a nuclear speckled pattern. Moreover, AF4 and ENL coeluted on sizing columns together with the known ENL binding partner Polycomb3, suggesting the presence of a multiprotein complex. The overexpression of ENL alone activated a reporter construct and a mutational screen indicated the conserved YEATS domain as essential for this function. Overlay and pulldown-assays finally showed a specific and YEATS domain-dependent association of ENL with histones H3 and H1. In summary, our studies support a common role for nuclear MLL fusion partners in chromatin biology.
引用
收藏
页码:5525 / 5532
页数:8
相关论文
共 50 条
  • [41] Leukemia-Associated MLL-AF10 Fusion Maintains an Active State of Chromatin on Its Target Genes By Recruiting Tip60
    Yamagata, Kazutsune
    Aikawa, Yukiko
    Shino, Mika
    Kitabayashi, Issay
    BLOOD, 2015, 126 (23)
  • [42] MLL translocation partners AF4, AF5q3l, and ENL associate in a higher order protein complex with CDK9 and cyclin T1.
    Lin, M
    Cleary, ML
    BLOOD, 2005, 106 (11) : 33A - 33A
  • [43] Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies
    Koken, MHM
    Reid, A
    Quignon, F
    ChelbiAlix, MK
    Davies, JM
    Kabarowski, JHS
    Zhu, J
    Dong, S
    Chen, SJ
    Chen, Z
    Tan, CC
    Licht, J
    Waxman, S
    deThe, H
    Zelent, A
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (19) : 10255 - 10260
  • [44] Activity of immunoproteasome inhibitor ONX-0914 in acute lymphoblastic leukemia expressing MLL-AF4 fusion protein
    Jenkins, Tyler W.
    Downey-Kopyscinski, Sondra L.
    Fields, Jennifer L.
    Rahme, Gilbert J.
    Colley, William C.
    Israel, Mark A.
    Maksimenko, Andrey, V
    Fiering, Steven N.
    Kisselev, Alexei F.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [45] Activity of immunoproteasome inhibitor ONX-0914 in acute lymphoblastic leukemia expressing MLL–AF4 fusion protein
    Tyler W. Jenkins
    Sondra L. Downey-Kopyscinski
    Jennifer L. Fields
    Gilbert J. Rahme
    William C. Colley
    Mark A. Israel
    Andrey V. Maksimenko
    Steven N. Fiering
    Alexei F. Kisselev
    Scientific Reports, 11
  • [46] Discovery of DDO-2213 as a Potent and Orally Bioavailable Inhibitor of the WDR5-Mixed Lineage Leukemia 1 Protein-Protein Interaction for the Treatment of MLL Fusion Leukemia
    Chen, Weilin
    Chen, Xin
    Li, Dongdong
    Zhou, Jianrui
    Jiang, Zhengyu
    You, Qidong
    Guo, Xiaoke
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (12) : 8221 - 8245
  • [47] MAP kinase activation is essential for the development of acute leukemia by MLL fusion protein and FLT3 tyrosine kinase mutation.
    Ono, Ryoichi
    Kumgai, Hidetoshi
    Nakajima, Hideaki
    Tonozuka, Yukio
    Hishiya, Ai
    Taki, Tomohiko
    Hayashi, Yasuhide
    Kitamura, Toshio
    Nosaka, Tetsuya
    BLOOD, 2006, 108 (11) : 586A - 586A
  • [48] DOT1L O-GlcNAcylation promotes its protein stability and MLL-fusion leukemia cell proliferation
    Song, Tanjing
    Zou, Qingli
    Yan, Yingying
    Lv, Suli
    Li, Neng
    Zhao, Xuefeng
    Ma, Xianyun
    Liu, Haigang
    Tang, Borui
    Sun, Lidong
    CELL REPORTS, 2021, 36 (12):
  • [49] The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies
    Xue, YT
    Gibbons, R
    Yan, ZJ
    Yang, DF
    McDowell, TL
    Sechi, S
    Qin, J
    Zhou, SL
    Higgs, D
    Wang, WD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (19) : 10635 - 10640
  • [50] Aberrant intracellular localization of set-can fusion protein, associated with a leukemia, disorganizes nuclear export
    Saito, S
    Miyaji-Yamaguchi, M
    Nagata, K
    INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (04) : 501 - 507